Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Strategies for viral inactivation

B Horowitz¹, E Ben-Hur

¹Melville Biologics, New York, USA.

Current Opinion in Hematology

|November 1, 1995

Summary

Virus inactivation methods significantly enhance the safety of blood products, especially pooled plasma derivatives. Ongoing research aims to extend these safety measures to all blood components, minimizing pathogen transmission risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Supracondylar fracture of the femur as a complication of the patellar tendon bearing cast: a case report.

Orthopedics·2014

Same author

Evaluation of the silicon phthalocyanine pc 4 for photodynamic bone marrow purging.

Journal of biomedical optics·2012

Same author

Photochemical decontamination of red cell concentrates with the silicon phthalocyanine pc 4 and red light.

Journal of biomedical optics·2012

Same author

Thermally enhanced radioresponse of cultured Chinese hamster cells: inhibition of repair of sublethal damage and enhancement of lethal damage. 1974.

Radiation research·2012

Same author

Laser-induced fluorescence of perylene in a microparticle suspension environment.

Analytical chemistry·2011

Same author

A note on the interaction between heterosis and photoperiodic response.

The Australian journal of science·2010

Area of Science:

Blood safety research
Infectious disease transmission
Pharmaceutical manufacturing

Background:

Donor screening reduces but cannot eliminate pathogen transmission via blood.
Pooled plasma derivatives require robust virus inactivation for safety.
Existing methods effectively mitigate enveloped virus transmission.

Purpose of the Study:

To evaluate the efficacy of virus inactivation in blood products.
To explore advanced inactivation techniques for broader application.
To achieve near-complete elimination of pathogen transmission risks.

Main Methods:

Review of current donor selection and screening protocols.
Analysis of established virus inactivation processes for plasma pools.
Investigation of emerging inactivation technologies for cellular blood products.

Main Results:

Virus inactivation dramatically improves the safety of pooled plasma derivatives.
Current methods have largely controlled enveloped virus transmission (e.g., HBV, HCV, HIV).
Newer methods promise pharmaceutical-grade safety for blood products.

Conclusions:

Virus inactivation is crucial for ensuring the safety of blood derivatives.
Advancements in inactivation technology are expanding safety to all blood components.
The goal is to render all blood products free from transmissible pathogens.

Related Experiment Videos